I’m surprised that my post asking people to keep this thread on...

I’m surprised that my post asking people to keep this thread on topic got removed for being off-topic. Ok....

I’ll try again and leave aside my preference to correct any factually wrong assertions about myself and my trading in SPL and another stem cell company.

A slightly amended version of my original post is:

’It would be better for all if the discussion remained on point rather than my trading @stano02. As you have Bpharm and Mpharm qualifications you should have a reasonably sound opinion on the merits or otherwise as to why our partner Lloyds is holding Viraleze back from any in-store availability for another 2 weeks. This seems strange for a product which purportedly can save lives during a pandemic and needs media and marketing attention to get maximum traction.

Boston Consulting Group (BCG) conducted qualitative and quantitative consumer research in Europe in November last year for Starpharma. They then also had input for pre-launch commercialisation strategies. Lloyds is our partner and running the show, not BCG.

Now back to the topic. Are Starpharma holders completely comfortable that Lloyds are choosing to not make Viraleze available in-store in a single store in their network for another 2 weeks?’

Thanks @idean for your quite saige comment about Lloyds and their self-interest and profit motive.